Albireo Pharma Inc
(ALBO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2012 | 09-2011 | 09-2010 | 09-2009 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,747 | -10,592 | -38,290 | -43,270 | -43,361 |
| Depreciation Amortization | 725 | 938 | 991 | 877 | 567 |
| Accounts receivable | -96 | 10 | -11 | N/A | N/A |
| Accounts payable and accrued liabilities | 63 | -1,767 | 982 | 194 | -1,374 |
| Other Working Capital | -51 | -906 | -3,957 | 2,066 | 1,008 |
| Other Operating Activity | 3,409 | -5,934 | 5,904 | 4,870 | 8,257 |
| Operating Cash Flow | $-16,697 | $-18,251 | $-34,381 | $-35,263 | $-34,903 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 6,000 | -6,000 | 25,614 | -25,614 |
| PPE Investments | -59 | -189 | -292 | -637 | -2,769 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -17 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -17 |
| Investing Cash Flow | $-59 | $5,811 | $-6,292 | $24,977 | $-28,400 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,587 | 25,326 | 8,780 | 25 | 47,831 |
| Common Stock Repurchased | 27 | 118 | 325 | 170 | 181 |
| Other Financing Activity | 8,491 | 2,775 | -150 | 0 | 0 |
| Financing Cash Flow | $17,105 | $28,219 | $8,955 | $195 | $48,012 |
| Beginning Cash Position | 38,701 | 22,922 | 54,640 | 64,731 | 80,022 |
| End Cash Position | 39,050 | 38,701 | 22,922 | 54,640 | 64,731 |
| Net Cash Flow | $349 | $15,779 | $-31,718 | $-10,091 | $-15,291 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,697 | -18,251 | -34,381 | -35,263 | -34,903 |
| Capital Expenditure | -59 | -189 | -292 | -637 | -2,769 |
| Free Cash Flow | -16,756 | -18,440 | -34,673 | -35,900 | -37,672 |